AnnJi’s AJ201 Shows Positive Clinical Signals in Phase 1/2a Trial for Rare Neuromuscular Disease SBMA

AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and...

May 23, 2025 | Friday | News
WuXi Biologics and CANbridge Launch China’s First Locally Developed Enzyme Replacement Therapy for Gaucher Disease

Enabled by WuXi Biologics' industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to ...

May 19, 2025 | Monday | News
Invivyd Urges FDA to Modernize COVID-19 Vaccine Evaluation Through Citizen Petition

Invivyd, Inc. announced it has submitted a Citizen Petition with the U.S. Food and Drug Administration (FDA) calling on the Agency to evolve from histori...

May 15, 2025 | Thursday | News
Eurofins Viracor Launches BAL Specimen Testing for NeXGen® Fungal/AFB NGS Assay to Transform Respiratory Infection Diagnostics

Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with...

May 08, 2025 | Thursday | News
BioAegis Launches Global 600-Patient Phase 2 Trial of rhu-pGSN to Treat ARDS and Advance Inflammation-Modulating Therapies

600-patient study to assess efficacy of rhu-pGSN, an immune system regulator that interrupts the NLRP3 inflammasome and boosts macrophage clearance of pa...

May 07, 2025 | Wednesday | News
Merck Makes $3.9 Billion Bet on Rare Tumors With SpringWorks Therapeutics Acquisition

  Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $...

April 29, 2025 | Tuesday | News
Insmed Announces Landmark Phase 3 ASPEN Study Results Demonstrating Brensocatib’s Breakthrough Potential in Bronchiectasis

Insmed Incorporated, a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patie...

April 24, 2025 | Thursday | News
President Trump Signs Executive Order to Lower Drug Prices, Focuses on Medicare Negotiations and Pharmacy Benefit Manager Reforms

President Trump issued an Executive Order titled Lowering Drug Prices by Once Again Putting Americans First on Tuesday, April 15. The Executive O...

April 18, 2025 | Friday | News
GSK Welcomes ACIP Vote to Recommend Arexvy for At-Risk Adults Aged 50–59

GSK plc is pleased that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including GSK&rsquo...

April 17, 2025 | Thursday | News
Pfizer Applauds CDC Panel’s Expanded Recommendation for RSV Vaccination in At-Risk Adults Aged 50–59

Pfizer Inc. announced  that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) vote...

April 17, 2025 | Thursday | News
Odylia Therapeutics Marks Rare Disease Day with Focus on Funding & Collaboration

Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event ...

April 11, 2025 | Friday | News
New Study Links SARS-CoV-2 Spike Protein Region to Autoantibody Production Potentially Driving Long COVID

 Long COVID or post COVID-19 syndrome, is a clinical entity observed in certain patients wherein symptoms of illness persist for at least several week...

April 10, 2025 | Thursday | News
Idorsia’s Aprocitentan Demonstrates Efficacy in African American Patients with Resistant Hypertension

Idorsia Ltd  announced the publication of "Aprocitentan for Blood Pressure Reduction in Black Patients” in the April edition of Hypertensio...

April 10, 2025 | Thursday | News
Assembly Biosciences Showcases Promising HSV Treatment Data at ESCMID 2025

Assembly Biosciences, Inc., a biotechnology company developing innovative therapeutics targeting serious viral diseases,  announced data from its herp...

April 10, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close